These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 15102858)

  • 1. Narrow substrate specificity and sensitivity toward ligand-binding site mutations of human T-cell Leukemia virus type 1 protease.
    Kádas J; Weber IT; Bagossi P; Miklóssy G; Boross P; Oroszlan S; Tözsér J
    J Biol Chem; 2004 Jun; 279(26):27148-57. PubMed ID: 15102858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bovine leukemia virus protease: comparison with human T-lymphotropic virus and human immunodeficiency virus proteases.
    Sperka T; Miklóssy G; Tie Y; Bagossi P; Zahuczky G; Boross P; Matúz K; Harrison RW; Weber IT; Tözsér J
    J Gen Virol; 2007 Jul; 88(Pt 7):2052-2063. PubMed ID: 17554040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substrates and inhibitors of human T-cell leukemia virus type I protease.
    Ding YS; Rich DH; Ikeda RA
    Biochemistry; 1998 Dec; 37(50):17514-8. PubMed ID: 9860866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the substrate specificity of the human T-cell leukemia virus and human immunodeficiency virus proteinases.
    Tözsér J; Zahuczky G; Bagossi P; Louis JM; Copeland TD; Oroszlan S; Harrison RW; Weber IT
    Eur J Biochem; 2000 Oct; 267(20):6287-95. PubMed ID: 11012683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of substrate cleavage by recombinant protease of human T cell leukaemia virus type 1 reveals preferences and specificity of binding.
    Daenke S; Schramm HJ; Bangham CR
    J Gen Virol; 1994 Sep; 75 ( Pt 9)():2233-9. PubMed ID: 8077922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The protease of human T-cell leukemia virus type-1 is a potential therapeutic target.
    Tözsér J; Weber IT
    Curr Pharm Des; 2007; 13(12):1285-94. PubMed ID: 17504236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substrates and inhibitors of human T-cell leukemia virus type 1 (HTLV-1) proteinase.
    Hrusková-Heidingsfeldová O; Bláha I; Urban J; Strop P; Pichová I
    Leukemia; 1997 Apr; 11 Suppl 3():45-6. PubMed ID: 9209292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding HTLV-I protease.
    Shuker SB; Mariani VL; Herger BE; Dennison KJ
    Chem Biol; 2003 May; 10(5):373-80. PubMed ID: 12770819
    [No Abstract]   [Full Text] [Related]  

  • 9. Stabilization from autoproteolysis and kinetic characterization of the human T-cell leukemia virus type 1 proteinase.
    Louis JM; Oroszlan S; Tözsér J
    J Biol Chem; 1999 Mar; 274(10):6660-6. PubMed ID: 10037763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alteration of substrate and inhibitor specificity of feline immunodeficiency virus protease.
    Lin YC; Beck Z; Lee T; Le VD; Morris GM; Olson AJ; Wong CH; Elder JH
    J Virol; 2000 May; 74(10):4710-20. PubMed ID: 10775609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular insights on analogs of HIV PR inhibitors toward HTLV-1 PR through QM/MM interactions and molecular dynamics studies: comparative structure analysis of wild and mutant HTLV-1 PR.
    Selvaraj C; Singh P; Singh SK
    J Mol Recognit; 2014 Dec; 27(12):696-706. PubMed ID: 25319617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a microtiter plate fluorescent assay for inhibition studies on the HTLV-1 and HIV-1 proteinases.
    Bagossi P; Kádas J; Miklóssy G; Boross P; Weber IT; Tözsér J
    J Virol Methods; 2004 Aug; 119(2):87-93. PubMed ID: 15158589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural basis for distinctions between substrate and inhibitor specificities for feline immunodeficiency virus and human immunodeficiency virus proteases.
    Lin YC; Beck Z; Morris GM; Olson AJ; Elder JH
    J Virol; 2003 Jun; 77(12):6589-600. PubMed ID: 12767979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered gag polyprotein cleavage specificity of feline immunodeficiency virus/human immunodeficiency virus mutant proteases as demonstrated in a cell-based expression system.
    Lin YC; Brik A; de Parseval A; Tam K; Torbett BE; Wong CH; Elder JH
    J Virol; 2006 Aug; 80(16):7832-43. PubMed ID: 16873240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of [Ile⁴⁰]HTLV-I protease inhibition assay using novel fluorogenic and chromogenic substrate.
    Kumada HO; Nguyen JT; Kakizawa T; Hidaka K; Kimura T; Hayashi Y; Kiso Y
    J Pept Sci; 2011 Aug; 17(8):569-75. PubMed ID: 21574213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-terminal residues of mature human T-lymphotropic virus type 1 protease are critical for dimerization and catalytic activity.
    Kádas J; Boross P; Weber IT; Bagossi P; Matúz K; Tözsér J
    Biochem J; 2008 Dec; 416(3):357-64. PubMed ID: 18636969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of inhibition of the retroviral protease by a Rous sarcoma virus peptide substrate representing the cleavage site between the gag p2 and p10 proteins.
    Cameron CE; Grinde B; Jentoft J; Leis J; Weber IT; Copeland TD; Wlodawer A
    J Biol Chem; 1992 Nov; 267(33):23735-41. PubMed ID: 1331099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amino acid preferences for a critical substrate binding subsite of retroviral proteases in type 1 cleavage sites.
    Bagossi P; Sperka T; Fehér A; Kádas J; Zahuczky G; Miklóssy G; Boross P; Tözsér J
    J Virol; 2005 Apr; 79(7):4213-8. PubMed ID: 15767422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of activity of the protease from bovine leukemia virus.
    Ménard A; Leonard R; Llido S; Geoffre S; Picard P; Berteau F; Precigoux G; Hospital M; Guillemain B
    FEBS Lett; 1994 Jun; 346(2-3):268-72. PubMed ID: 8013645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural basis for specificity of retroviral proteases.
    Wu J; Adomat JM; Ridky TW; Louis JM; Leis J; Harrison RW; Weber IT
    Biochemistry; 1998 Mar; 37(13):4518-26. PubMed ID: 9521772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.